BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3437 related articles for article (PubMed ID: 15961574)

  • 1. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of purified allogeneic CD4(+) T cells by rat bone marrow-derived dendritic cells induces concurrent secretion of IFN-gamma, IL-4, and IL-10.
    Janelidze S; Enell K; Visse E; Darabi A; Salford LG; Siesjö P
    Immunol Lett; 2005 Nov; 101(2):193-201. PubMed ID: 16002150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of PGE(2) in the differentiation of dendritic cells: how do dendritic cells influence T-cell polarization and chemokine receptor expression?
    Lee JJ; Takei M; Hori S; Inoue Y; Harada Y; Tanosaki R; Kanda Y; Kami M; Makimoto A; Mineishi S; Kawai H; Shimosaka A; Heike Y; Ikarashi Y; Wakasugi H; Takaue Y; Hwang TJ; Kim HJ; Kakizoe T
    Stem Cells; 2002; 20(5):448-59. PubMed ID: 12351815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells generated in the presence of interferon-alpha stimulate allogeneic CD4+ T-cell proliferation: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells.
    Carbonneil C; Saidi H; Donkova-Petrini V; Weiss L
    Int Immunol; 2004 Jul; 16(7):1037-52. PubMed ID: 15184347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UVB-irradiated dendritic cells are impaired in their APC function and tolerize primed Th1 cells but not naive CD4+ T cells.
    Denfeld RW; Hara H; Tesmann JP; Martin S; Simon JC
    J Leukoc Biol; 2001 Apr; 69(4):548-54. PubMed ID: 11310840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells induced in the presence of GM-CSF and IL-5.
    Yi H; Zhang L; Zhen Y; He X; Zhao Y
    Cytokine; 2007 Jan; 37(1):35-43. PubMed ID: 17382554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
    Mejri N; Brossard M
    Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression.
    Ozawa H; Aiba S; Nakagawa ; Tagami H
    Eur J Immunol; 1996 Mar; 26(3):648-52. PubMed ID: 8605933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of interleukin-10 on dendritic cell maturation and function.
    De Smedt T; Van Mechelen M; De Becker G; Urbain J; Leo O; Moser M
    Eur J Immunol; 1997 May; 27(5):1229-35. PubMed ID: 9174615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells.
    Nakamura T; Kamogawa Y; Bottomly K; Flavell RA
    J Immunol; 1997 Feb; 158(3):1085-94. PubMed ID: 9013946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells generated in the presence of GM-CSF plus IL-15 prime potent CD8+ Tc1 responses in vivo.
    Pulendran B; Dillon S; Joseph C; Curiel T; Banchereau J; Mohamadzadeh M
    Eur J Immunol; 2004 Jan; 34(1):66-73. PubMed ID: 14971031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response.
    DiIulio NA; Xu H; Fairchild RL
    Eur J Immunol; 1996 Nov; 26(11):2606-12. PubMed ID: 8921946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
    Schweitzer AN; Sharpe AH
    J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2 sensitization.
    Kuipers H; Heirman C; Hijdra D; Muskens F; Willart M; van Meirvenne S; Thielemans K; Hoogsteden HC; Lambrecht BN
    J Leukoc Biol; 2004 Nov; 76(5):1028-38. PubMed ID: 15316032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions.
    Wells JW; Darling D; Farzaneh F; Galea-Lauri J
    Scand J Immunol; 2005 Mar; 61(3):251-9. PubMed ID: 15787742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase kinase 3 activity during development of bone marrow-derived dendritic cells (DCs) essential for the DC function to induce T helper 2 polarization.
    Ono T; Yanagawa Y; Iwabuchi K; Nonomura K; Onoé K
    Immunology; 2007 Oct; 122(2):189-98. PubMed ID: 17490435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cadinol and calamenene induce dendritic cells from human monocytes and drive Th1 polarization.
    Takei M; Umeyama A; Arihara S
    Eur J Pharmacol; 2006 May; 537(1-3):190-9. PubMed ID: 16631732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication.
    Wu SF; Liu TM; Lin YC; Sytwu HK; Juan HF; Chen ST; Shen KL; Hsi SC; Hsieh SL
    J Leukoc Biol; 2004 Feb; 75(2):293-306. PubMed ID: 14634066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-beta induces the development of type 2 dendritic cells.
    Huang YM; Hussien Y; Yarilin D; Xiao BG; Liu YJ; Link H
    Cytokine; 2001 Mar; 13(5):264-71. PubMed ID: 11243704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 172.